| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-10 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.24 | 7e-10 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.19 | 5e-09 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.22 | 7e-09 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-08 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-08 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-08 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-07 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-07 |